Metabolic · Liver
HRT and NAFLD/MASLD in midlife women
NAFLD (now called MASLD) rises sharply after menopause. Estrogen regulates hepatic lipid metabolism, and its decline is one reason midlife women catch up to men in fatty liver prevalence. Transdermal HRT bypasses the liver and is preferred in this group.
Practical picks
- Transdermal estradiol
- Micronized progesterone
- Address weight, insulin resistance, alcohol
Frequently asked questions
Can I take HRT with fatty liver?
Yes — transdermal is preferred to avoid first-pass hepatic load.
Does HRT worsen liver enzymes?
Oral estrogen can transiently. Transdermal generally does not.
Does HRT help NAFLD?
Observational data suggest reduced NAFLD prevalence and severity in HRT users.
Considering a physician-supervised longevity protocol? Kindr Health evaluates peptide therapy as part of personalized perimenopause and menopause care.
Request your Longevity Consult →Explore Kindr Health
Related: FDA peptide review July 2026 briefing · Peptide therapy hub · Longevity service
Written and medically reviewed by the Kindr Health Clinical Team · Published 2026-06-19 · Last reviewed 2026-07-01. Compounded medications are prepared by FDA-registered 503A pharmacies and are not FDA-approved drug products.